Loading
TP
Tetralogic Pharmaceuticals Corp Stock: price and insider trades · United States
Tetralogic Pharmaceuticals Corp: what insiders have been doing
Tetralogic Pharmaceuticals Corp belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). No insider at Tetralogic Pharmaceuticals Corp has published a filing in the past twelve months. The most recent one dates from 10 February 2016.
Our records for Tetralogic Pharmaceuticals Corp go back to 2016, with no purchases and 11 sales on the open market in total.
In the same sector, recent insider purchases at Xenon Pharmaceuticals Inc. and Vivos Inc also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
11
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€418,779
11 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2015FY ended December 2015 · cache
US$0.00
Analyst consensus
Income statement
EBITDA-US$21.1M
Net income-US$42.8M0.0% margin
Valuation
Beta-73.60
Profitability & ownership
ROA-19.6%
% institutions0.0%
Last declaration on 10 February 2016
Declarations11 total
103,123 shares@ US$0.194.2% of flowCommon StockSEC:0001012975-16-000991:0
230,507 shares@ US$0.167.9% of flowCommon StockSEC:0001012975-16-000991:1
82,583 shares@ US$0.152.7% of flowCommon StockSEC:0001012975-16-000980:0
832,881 shares@ US$0.2035.5% of flowCommon StockSEC:0001012975-16-000980:2
500,026 shares@ US$0.1415.1% of flowCommon StockSEC:0001012975-16-000980:1
176,306 shares@ US$0.176.6% of flowCommon StockSEC:0001012975-16-000957:2
52,826 shares@ US$0.263.0% of flowCommon StockSEC:0001012975-16-000957:0
140,000 shares@ US$0.206.2% of flowCommon StockSEC:0001012975-16-000957:1
209,984 shares@ US$0.2712.5% of flowCommon StockSEC:0001012975-16-000938:1
69,425 shares@ US$0.304.6% of flowCommon StockSEC:0001012975-16-000938:0
32,521 shares@ US$0.261.9% of flowCommon StockSEC:0001012975-16-000938:2
11 of 11 declarations
About Tetralogic Pharmaceuticals Corp
Tetralogic Pharmaceuticals Corp is a company focused on developing innovative treatments for serious diseases. It is listed on NASDAQ.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
